Prednisolone

(redirected from Orapred)
Also found in: Dictionary, Thesaurus, Medical.

prednisolone

[pred′nis·ə‚lōn]
(biochemistry)
C21H28O5 A glucocorticoid that is a dehydrogenated analog of hydrocortisone.

Prednisolone

 

a synthetic medication; a hormonal preparation. It has an anti-inflammatory and antiallergic effect. It is used in the form of tablets, a solution for injection, and ointments for the treatment of rheumatism, arthritis, some kidney diseases, and bronchial asthma.

References in periodicals archive ?
The increase was partially offset by revenue declines in Kapvay, Orapred and Ulesfia.
The transaction should provide three significant financial and strategic benefits to BioMarin: The transaction is expected to generate significant cash flow and accelerate BioMarin's goal of reaching profitability Net sales of Orapred are expected to be about $42 million for the 12 months that will end December 31, 2004.
Sciele continues to gain market share for Allegra Oral Suspension and Orapred ODT.
This product is the first generic version of Shionogi's Orapred ODT.
CIMA could terminate Alliant's license in connection with Orapred on 30-days notice.
consists of the following products: ADHD-treatment Kapvay[R] (clonidine extended release tablets), head lice treatment Ulesfia[R] (benzyl alcohol) Lotion, asthma-related medication Orapred ODT[R] (prednisolone sodium phosphate orally disintegrating tablets), irritable bowel syndrome treatment Donnatal[R] (belladonna alkaloids, phenobarbital) and Zonegran[R] (zonisamide) for treatment of partial seizures in adults with epilepsy.
The license in connection with Orapred could be terminated on 30-days notice.